Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Using a CO2 rebreather to improve blood pressure in patients with neurogenic orthostatic hypotension

Official title: CO2 Rebreathing to Increase Blood Pressure in Neurogenic Orthostatic Hypotension: A Proof-of-Concept Pilot Study

Run by University of Calgary · NCT05908760 · Data updated 2026-11-12

This study is testing whether a CO2 rebreather can help people with neurogenic orthostatic hypotension improve their blood pressure and feel better when standing up.

More Orthostatic Hypotension trials

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment28 (estimated)
SponsorUniversity of Calgary
Academic / other
Locations1 site (Calgary, Alberta)
StatusRecruiting
StartedJuly 30, 2024
Main results expectedDecember 31, 2029
Study endsDecember 31, 2030
Registry record updatedMay 5, 2026
Trial IDNCT05908760 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with a physician diagnosis of neurogenic orthostatic hypotension.

Probably not a fit

Patients with chronic heart failure, severe pulmonary disease, or other systemic illnesses affecting autonomic function may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study evaluates the effectiveness of a CO2 rebreather device in improving blood pressure and orthostatic tolerance in patients diagnosed with neurogenic orthostatic hypotension (nOH). The study is based on the hypothesis that increasing arterial CO2 levels through rebreathing can enhance blood pressure responses in these patients. The intervention involves capturing and re-inhaling expired CO2 to transiently elevate CO2 levels, potentially offering a novel treatment approach for managing nOH symptoms. The study will include 28 participants who meet specific eligibility criteria and will be conducted at the University of Calgary.

Why it matters

Potential benefit: If successful, this approach could significantly improve blood pressure regulation and quality of life for patients suffering from neurogenic orthostatic hypotension.

How similar studies have gone: While this approach is novel, previous studies have indicated that hypercapnia can improve blood pressure in patients with nOH, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Male and Female
* Physician diagnosis of Neurogenic Orthostatic Hypotension
* Non-smokers.
* Able and willing to provide informed consent.
* Ability to travel to Libin Cardiovascular Institute Autonomic Testing Lab at the University of Calgary, Calgary, AB.

Exclusion Criteria:

* Medical therapies or medications which could interfere with testing of autonomic function
* Pregnant or breast-feeding females
* Subjects with chronic heart failure or severe pulmonary disease who are unable to climb one flight of stairs due to shortness of breath.
* Presence of failure of other organ systems or systemic illness that can affect autonomic function or the participant's ability to cooperate. These include dementia, alcohol and/or drug abuse, cerebrovascular disease, kidney or liver disease, surgical procedures where the nerves of the sympathetic nervous system have been cut.
* Other factors which in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies.

Where it's running

  • University of Calgary
    Calgary, Alberta, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.